Shelby Saunders

Cooley advised Dualitas, a biotechnology company pioneering next-generation bispecific antibody therapies for immunology and inflammation, on its $65 million Series A financing, to advance a portfolio of next-generation bispecific antibodies, including lead programs DTX-103 in allergic disease and DTX-102 for autoimmune disease, and to accelerate the development of Dualitas’ proprietary DualScreen BsAb discovery engine.

Cooley advised EliseAI, an artificial intelligence company automating complex healthcare and housing systems, on the close of its $250 million Series E financing.

Cooley advised Contentsquare, an all-in-one experience intelligence platform, on its definitive agreement to acquire Loris AI, a conversation intelligence platform, to give business leaders a deeper, more accurate view of the full customer journey – from click to conversation.

Cooley advised Rubrik (NYSE: RBRK), a leading cybersecurity company, on its agreement to acquire Predibase to accelerate agentic artificial intelligence adoption from pilot to production at scale. 

Cooley advised Tenable, an exposure management company, on its definitive agreement to acquire Apex Security, an innovator in securing the rapidly expanding artificial intelligence attack surface.